Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2021-04-01
2022-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
NCT06540989
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
NCT04273672
Measures of Motor Impairment in Early Parkinson's Disease
NCT00291265
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
NCT05808504
A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease
NCT05421832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speakers
Participants will be recording sentences using a customized app, which is the focus of the current investigation. There is no arm per se, as the current investigation does not involve an intervention. The current investigation aims at developing and pilot testing an app.
Understand Me For Life
The aim of the current investigation is to test the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Understand Me For Life
The aim of the current investigation is to test the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have experienced changes in your voice (e.g., your voice has "lost its strength") and your voice is a current concern
* Have not received individual speech therapy for the past 2 years (group therapy is ok)
* Have a stable medication schedule
* Have not received DBS (Deep Brain Stimulation)
* Are a native speaker of American English
* Be a native speaker of American English
* Have no history of neurological impairment
* Have no history of speech or language problems
* Be a native speaker of American English
* Be between 18-55 years old
* Have no history of speech-language-hearing problems
* Pass a free hearing screening
* Have received the Covid19 vaccine
Exclusion Criteria
Healthy controls:
* If criteria above are not met
Listeners:
* If criteria above are not met
30 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Long Island University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gemma Moya Gale
Assistant Professor, CCC-SLP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gemma Moya Gale, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Long Island University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Long Island University
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21/01-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.